Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Olanzapine 10-N-glucuronide. A tertiary N-glucuronide unique to humans.

Kassahun K, Mattiuz E, Franklin R, Gillespie T.

Drug Metab Dispos. 1998 Sep;26(9):848-55. Review.

PMID:
9733662
[PubMed - indexed for MEDLINE]
Free Article
2.

Disposition and biotransformation of the antipsychotic agent olanzapine in humans.

Kassahun K, Mattiuz E, Nyhart E Jr, Obermeyer B, Gillespie T, Murphy A, Goodwin RM, Tupper D, Callaghan JT, Lemberger L.

Drug Metab Dispos. 1997 Jan;25(1):81-93.

PMID:
9010634
[PubMed - indexed for MEDLINE]
Free Article
3.

Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.

Mattiuz E, Franklin R, Gillespie T, Murphy A, Bernstein J, Chiu A, Hotten T, Kassahun K.

Drug Metab Dispos. 1997 May;25(5):573-83.

PMID:
9152596
[PubMed - indexed for MEDLINE]
Free Article
4.

Tertiary N-glucuronides of clozapine and its metabolite desmethylclozapine in patient urine.

Breyer-Pfaff U, Wachsmuth H.

Drug Metab Dispos. 2001 Oct;29(10):1343-8.

PMID:
11560879
[PubMed - indexed for MEDLINE]
Free Article
5.

Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography/tandem mass spectrometry.

Murphy AT, Lake BG, Bernstein JR, Franklin RB, Gillespie TA.

J Mass Spectrom. 1998 Dec;33(12):1237-45.

PMID:
9875525
[PubMed - indexed for MEDLINE]
6.

N(+)-glucuronidation of aliphatic tertiary amines in human: antidepressant versus antipsychotic drugs.

Luo H, Hawes EM, McKay G, Korchinski ED, Midha KK.

Xenobiotica. 1995 Mar;25(3):291-301.

PMID:
7618355
[PubMed - indexed for MEDLINE]
7.

Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.

Macias WL, Bergstrom RF, Cerimele BJ, Kassahun K, Tatum DE, Callaghan JT.

Pharmacotherapy. 1998 Nov-Dec;18(6):1237-48.

PMID:
9855322
[PubMed - indexed for MEDLINE]
8.

Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.

Bogusz MJ, Kr├╝ger KD, Maier RD, Erkwoh R, Tuchtenhagen F.

J Chromatogr B Biomed Sci Appl. 1999 Sep 24;732(2):257-69.

PMID:
10517347
[PubMed - indexed for MEDLINE]
9.

Quaternary ammonium glucuronide of croconazole in rabbits.

Takeuchi M, Nakano M, Mizojiri K, Iwatani K, Nakagawa Y, Kikuchi J, Terui Y.

Xenobiotica. 1989 Nov;19(11):1327-36.

PMID:
2618084
[PubMed - indexed for MEDLINE]
10.

A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes.

Gardner I, Zahid N, MacCrimmon D, Uetrecht JP.

Mol Pharmacol. 1998 Jun;53(6):991-8.

PMID:
9614200
[PubMed - indexed for MEDLINE]
Free Article
11.

A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo.

Gardner I, Leeder JS, Chin T, Zahid N, Uetrecht JP.

Mol Pharmacol. 1998 Jun;53(6):999-1008.

PMID:
9614201
[PubMed - indexed for MEDLINE]
Free Article
12.

N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group.

Hawes EM.

Drug Metab Dispos. 1998 Sep;26(9):830-7. Review.

PMID:
9733660
[PubMed - indexed for MEDLINE]
Free Article
13.

A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine.

Boulton DW, Markowitz JS, DeVane CL.

J Chromatogr B Biomed Sci Appl. 2001 Aug 15;759(2):319-23.

PMID:
11499485
[PubMed - indexed for MEDLINE]
14.

Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronide.

Janssen FW, Kirkman SK, Fenselau C, Stogniew M, Hofmann BR, Young EM, Ruelius HW.

Drug Metab Dispos. 1982 Nov-Dec;10(6):599-604.

PMID:
6130907
[PubMed - indexed for MEDLINE]
15.

Predicting drug interactions and pharmacokinetic variability with in vitro methods: the olanzapine experience.

Wrighton SA, Ring BJ.

Drug Metab Rev. 1999 Feb;31(1):15-28. Review. No abstract available.

PMID:
10065363
[PubMed - indexed for MEDLINE]
16.

The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.

Markowitz JS, Devane CL, Liston HL, Boulton DW, Risch SC.

Clin Pharmacol Ther. 2002 Jan;71(1):30-8.

PMID:
11823755
[PubMed - indexed for MEDLINE]
17.

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM.

Clin Pharmacokinet. 1999 Sep;37(3):177-93. Review.

PMID:
10511917
[PubMed - indexed for MEDLINE]
18.

Olanzapine transfer by human placenta.

Schenker S, Yang Y, Mattiuz E, Tatum D, Lee M.

Clin Exp Pharmacol Physiol. 1999 Sep;26(9):691-7.

PMID:
10499158
[PubMed - indexed for MEDLINE]
19.

Application of electrospray mass spectrometry in the identification of intact glucuronide and suplate conjugates of clozapine in rat.

Zhang GO, McKay G, Hubbard JW, Midha KK.

Xenobiotica. 1996 May;26(5):541-50.

PMID:
8736064
[PubMed - indexed for MEDLINE]
20.

Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins.

Green MD, Tephly TR.

Drug Metab Dispos. 1998 Sep;26(9):860-7. Review.

PMID:
9733664
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk